São Paulo - Delayed Quote BRL

Walgreens Boots Alliance, Inc. (WGBA34.SA)

Compare
27.14 +0.04 (+0.15%)
At close: November 29 at 6:05 PM GMT-3

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in BRL.
NameTitlePayExercisedYear Born
Mr. Stefano Pessina Executive Chairman of the Board 367.72k -- 1941
Mr. Manmohan Mahajan Executive VP & Global CFO 6.4M -- 1980
Ms. Ornella Barra Chief Operating Officer of International 7.96M -- 1953
Mr. Timothy C. Wentworth CEO & Director -- -- 1960
Mr. Todd D. Heckman Senior VP, Global Controller & Chief Accounting Officer -- -- 1974
Dr. Neal Joseph Sample Ph.D. Executive VP & Chief Information Officer -- -- 1975
Ms. Tiffany Ann Kanaga Vice President of Global Investor Relations -- -- --
Mr. Matthew D'Ambrosio Senior VP and Global Chief Compliance & Ethics Officer -- -- 1970
Ms. Lanesha T. Minnix J.D. Executive VP & Global Chief Legal Officer -- -- 1975
Ms. Elizabeth L. Burger Executive VP & Chief Human Resources Officer -- -- 1971

Walgreens Boots Alliance, Inc.

108 Wilmot Road
Deerfield, IL 60015
United States
847 315 3700 https://www.walgreensbootsalliance.com
Sector: 
Healthcare
Full Time Employees: 
193,000

Description

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Corporate Governance

Walgreens Boots Alliance, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 2, 2025 at 12:00 PM UTC - January 6, 2025 at 12:00 PM UTC

Walgreens Boots Alliance, Inc. Earnings Date

Recent Events

November 14, 2024 at 12:00 AM UTC

Ex-Dividend Date